Yehia L, Keel E, Eng C (2020) The clinical spectrum of PTEN mutations. Annu Rev Med 71:103–116

Article  CAS  PubMed  Google Scholar 

Ngeow J, Eng C (2015) PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol. Methods 77–78:11–19

Article  PubMed  Google Scholar 

Tan M-H, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C (2012) Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 18:400–407

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jelsig AM, Rønlund K, Gede LB, Frederiksen JH, Karstensen JG, Birkedal U, van Overeem Hansen T (2023) Identification of a novel pathogenic deep intronic variant in PTEN resulting in pseudoexon inclusion in a patient with juvenile polyps. J Hum Genet 68:721–724

Article  CAS  PubMed  Google Scholar 

Crivelli L, Bubien V, Jones N, Chiron J, Bonnet F, Barouk-Simonet E, Couzigou P, Sevenet N, Caux F, Longy M (2017) Insertion of Alu elements at a PTEN hotspot in Cowden syndrome. Eur J Hum Genet 25:1087–1091

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teresi RE, Zbuk KM, Pezzolesi MG, Waite KA, Eng C (2007) Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation. Am J Hum Genet 81:756–767

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yehia L, Eng C, 65 YEARS OF THE DOUBLE HELIX (2018) One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine. Endocr Relat Cancer 25:T121–T140

Article  CAS  PubMed  Google Scholar 

Guo X, Shi J, Cai Q, Shu X-O, He J, Wen W, Allen J, Pharoah P, Dunning A, Hunter DJ, Kraft P, Easton DF, Zheng W, Long J (2018) Use of deep whole-genome sequencing data to identify structure risk variants in breast cancer susceptibility genes. Hum Mol Genet 27:853–859

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tusseau M, Eyries M, Chatron N, Coulet F, Guichet A, Colin E, Demeer B, Maillard H, Thevenon J, Lavigne C, Saillour V, Paris C, De Sainte Agathe JM, Pujalte M, Guilhem A, Dupuis-Girod S, Lesca G (2024) Genome sequencing identify chromosome 9 inversions disrupting ENG in 2 unrelated HHT families. Eur J Med Genet 68:104919

Article  CAS  PubMed  Google Scholar 

Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, Kosmicki JA, Arbelaez J, Cui W, Schwartz GB, Chow ED, Kanterakis E, Gao H, Kia A, Batzoglou S, Sanders SJ (2019) Farh KK-H. predicting splicing from primary sequence with deep learning. Cell 176:535-548e24

Article  CAS  PubMed  Google Scholar 

Mester JL, Ghosh R, Pesaran T, Huether R, Karam R, Hruska KS, Costa HA, Lachlan K, Ngeow J, Barnholtz-Sloan J, Sesock K, Hernandez F, Zhang L, Milko L, Plon SE, Hegde M, Eng C (2018) Gene-specific criteria for PTEN variant curation: recommendations from the ClinGen PTEN expert panel. Hum Mutat 39:1581–1592

Article  PubMed  Google Scholar 

Davy G, Rousselin A, Goardon N, Castéra L, Harter V, Legros A, Muller E, Fouillet R, Brault B, Smirnova AS, Lemoine F, de la Grange P, Guillaud-Bataille M, Caux-Moncoutier V, Houdayer C, Bonnet F, Blanc-Fournier C, Gaildrat P, Frebourg T, Martins A, Vaur D, Krieger S (2017) Detecting splicing patterns in genes involved in hereditary breast and ovarian cancer. Eur J Hum Genet 25:1147–1154

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leman R, Harter V, Atkinson A, Davy G, Rousselin A, Muller E, Castéra L, Lemoine F, de la Grange P, Guillaud-Bataille M, Vaur D, Krieger S (2020) SpliceLauncher: a tool for detection, annotation and relative quantification of alternative junctions from RNAseq data. Bioinformatics 36:1634–1636

Article  CAS  PubMed  Google Scholar 

Pacot L, Pelletier V, Chansavang A, Briand-Suleau A, Burin des Roziers C, Coustier A, Maillard T, Vaucouleur N, Orhant L, Barbance C, Lermine A, Hamzaoui N, Hadjadj D, Laurendeau I, El Khattabi L, Nectoux J, Vidaud M, Parfait B, Dollfus H, Pasmant E, Vidaud D (2023) Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1. Hum Genet 142:1–9

Article  CAS  PubMed  Google Scholar 

Davidson AL, Dressel U, Norris S, Canson DM, Glubb DM, Fortuno C, Hollway GE, Parsons MT, Vidgen ME, Holmes O, Koufariotis LT, Lakis V, Leonard C, Wood S, Xu Q, McCart Reed AE, Pickett HA, Al-Shinnag MK, Austin RL, Burke J, Cops EJ, Nichols CB, Goodwin A, Harris MT, Higgins MJ, Ip EL, Kiraly-Borri C, Lau C, Mansour JL, Millward MW, Monnik MJ, Pachter NS, Ragunathan A, Susman RD, Townshend SL, Trainer AH, Troth SL, Tucker KM, Wallis MJ, Walsh M, Williams RA, Winship IM, Newell F, Tudini E, Pearson JV, Poplawski NK, Mar Fan HG, James PA, Spurdle AB, Waddell N, Ward RL (2023) The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study. Genome Med 15:74

Article  PubMed  PubMed Central  Google Scholar 

Schroeder C, Faust U, Krauße L, Liebmann A, Abele M, Demidov G, Schütz L, Kelemen O, Pohle A, Gauß S, Sturm M, Roggia C, Streiter M, Buchert R, Armenau-Ebinger S, Nann D, Beschorner R, Handgretinger R, Ebinger M, Lang P, Holzer U, Skokowa J, Ossowski S, Haack TB, Mau-Holzmann UA, Dufke A, Riess O, Brecht IB (2023) Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients. Eur J Hum Genet 31:1139–1146

Article  CAS  PubMed  PubMed Central  Google Scholar